nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—systemic lupus erythematosus	0.516	0.748	CbGaD
Pseudoephedrine—TNF—systemic lupus erythematosus	0.174	0.252	CbGaD
Pseudoephedrine—IL2—synovial fluid—systemic lupus erythematosus	0.0269	0.327	CbGeAlD
Pseudoephedrine—IL2—blood plasma—systemic lupus erythematosus	0.00546	0.0665	CbGeAlD
Pseudoephedrine—NFATC1—connective tissue—systemic lupus erythematosus	0.00318	0.0387	CbGeAlD
Pseudoephedrine—IL2—connective tissue—systemic lupus erythematosus	0.00291	0.0354	CbGeAlD
Pseudoephedrine—IL2—skin of body—systemic lupus erythematosus	0.00262	0.032	CbGeAlD
Pseudoephedrine—IL2—kidney—systemic lupus erythematosus	0.00247	0.0301	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—systemic lupus erythematosus	0.00232	0.0283	CbGeAlD
Pseudoephedrine—NFATC1—tendon—systemic lupus erythematosus	0.00218	0.0266	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—systemic lupus erythematosus	0.00212	0.0259	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—systemic lupus erythematosus	0.00212	0.0258	CbGeAlD
Pseudoephedrine—IL2—bone marrow—systemic lupus erythematosus	0.00193	0.0236	CbGeAlD
Pseudoephedrine—NFATC1—lung—systemic lupus erythematosus	0.00192	0.0233	CbGeAlD
Pseudoephedrine—NFATC1—nervous system—systemic lupus erythematosus	0.00177	0.0216	CbGeAlD
Pseudoephedrine—IL2—lung—systemic lupus erythematosus	0.00175	0.0213	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—systemic lupus erythematosus	0.00171	0.0208	CbGeAlD
Pseudoephedrine—IL2—nervous system—systemic lupus erythematosus	0.00162	0.0198	CbGeAlD
Pseudoephedrine—IL2—central nervous system—systemic lupus erythematosus	0.00156	0.019	CbGeAlD
Pseudoephedrine—SLC6A4—blood plasma—systemic lupus erythematosus	0.00132	0.0161	CbGeAlD
Pseudoephedrine—CYP2D6—urine—systemic lupus erythematosus	0.00122	0.0149	CbGeAlD
Pseudoephedrine—MAOA—blood plasma—systemic lupus erythematosus	0.00107	0.0131	CbGeAlD
Pseudoephedrine—ADRA2A—blood plasma—systemic lupus erythematosus	0.000822	0.01	CbGeAlD
Pseudoephedrine—ADRB1—connective tissue—systemic lupus erythematosus	0.000728	0.00887	CbGeAlD
Pseudoephedrine—CYP2D6—blood plasma—systemic lupus erythematosus	0.000637	0.00776	CbGeAlD
Pseudoephedrine—MAOA—connective tissue—systemic lupus erythematosus	0.000571	0.00695	CbGeAlD
Pseudoephedrine—MAOA—nephron tubule—systemic lupus erythematosus	0.000553	0.00673	CbGeAlD
Pseudoephedrine—MAOA—kidney—systemic lupus erythematosus	0.000486	0.00592	CbGeAlD
Pseudoephedrine—MAOA—cortex of kidney—systemic lupus erythematosus	0.000473	0.00576	CbGeAlD
Pseudoephedrine—SLC6A3—lung—systemic lupus erythematosus	0.000463	0.00564	CbGeAlD
Pseudoephedrine—ADRB1—lung—systemic lupus erythematosus	0.000439	0.00535	CbGeAlD
Pseudoephedrine—ADRA2A—connective tissue—systemic lupus erythematosus	0.000438	0.00533	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—systemic lupus erythematosus	0.000429	0.00522	CbGeAlD
Pseudoephedrine—SLC6A4—lung—systemic lupus erythematosus	0.000424	0.00517	CbGeAlD
Pseudoephedrine—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000421	0.00513	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—systemic lupus erythematosus	0.000413	0.00503	CbGeAlD
Pseudoephedrine—ADRB1—nervous system—systemic lupus erythematosus	0.000407	0.00495	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—systemic lupus erythematosus	0.000393	0.00479	CbGeAlD
Pseudoephedrine—MAOA—tendon—systemic lupus erythematosus	0.000392	0.00478	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—systemic lupus erythematosus	0.000392	0.00477	CbGeAlD
Pseudoephedrine—SLC6A4—central nervous system—systemic lupus erythematosus	0.000378	0.00461	CbGeAlD
Pseudoephedrine—SLC6A2—lung—systemic lupus erythematosus	0.000374	0.00455	CbGeAlD
Pseudoephedrine—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000363	0.00442	CbGeAlD
Pseudoephedrine—SLC6A2—nervous system—systemic lupus erythematosus	0.000346	0.00421	CbGeAlD
Pseudoephedrine—MAOA—lung—systemic lupus erythematosus	0.000344	0.00419	CbGeAlD
Pseudoephedrine—SLC6A2—central nervous system—systemic lupus erythematosus	0.000333	0.00406	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—systemic lupus erythematosus	0.000322	0.00392	CbGeAlD
Pseudoephedrine—MAOA—nervous system—systemic lupus erythematosus	0.000319	0.00388	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—systemic lupus erythematosus	0.00031	0.00377	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—systemic lupus erythematosus	0.000307	0.00374	CbGeAlD
Pseudoephedrine—ADRA2A—tendon—systemic lupus erythematosus	0.000301	0.00367	CbGeAlD
Pseudoephedrine—CYP2D6—kidney—systemic lupus erythematosus	0.000289	0.00352	CbGeAlD
Pseudoephedrine—ADRA2A—lung—systemic lupus erythematosus	0.000264	0.00322	CbGeAlD
Pseudoephedrine—Hypertension—Leflunomide—systemic lupus erythematosus	0.000262	0.00474	CcSEcCtD
Pseudoephedrine—Hallucination—Mycophenolate mofetil—systemic lupus erythematosus	0.000261	0.00472	CcSEcCtD
Pseudoephedrine—Chest pain—Leflunomide—systemic lupus erythematosus	0.000258	0.00467	CcSEcCtD
Pseudoephedrine—Anxiety—Leflunomide—systemic lupus erythematosus	0.000257	0.00465	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Prednisone—systemic lupus erythematosus	0.000251	0.00454	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisolone—systemic lupus erythematosus	0.000249	0.00451	CcSEcCtD
Pseudoephedrine—Irritability—Prednisone—systemic lupus erythematosus	0.000245	0.00444	CcSEcCtD
Pseudoephedrine—ADRA2A—nervous system—systemic lupus erythematosus	0.000245	0.00298	CbGeAlD
Pseudoephedrine—Bradycardia—Hydrocortisone—systemic lupus erythematosus	0.000243	0.0044	CcSEcCtD
Pseudoephedrine—Tachycardia—Leflunomide—systemic lupus erythematosus	0.000241	0.00437	CcSEcCtD
Pseudoephedrine—Arrhythmia—Cyclosporine—systemic lupus erythematosus	0.00024	0.00434	CcSEcCtD
Pseudoephedrine—Sweating—Methylprednisolone—systemic lupus erythematosus	0.00024	0.00434	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Leflunomide—systemic lupus erythematosus	0.000239	0.00433	CcSEcCtD
Pseudoephedrine—Hallucination—Hydrocortisone—systemic lupus erythematosus	0.000238	0.0043	CcSEcCtD
Pseudoephedrine—Anorexia—Leflunomide—systemic lupus erythematosus	0.000236	0.00427	CcSEcCtD
Pseudoephedrine—ADRA2A—central nervous system—systemic lupus erythematosus	0.000235	0.00287	CbGeAlD
Pseudoephedrine—Arrhythmia—Mycophenolate mofetil—systemic lupus erythematosus	0.000234	0.00424	CcSEcCtD
Pseudoephedrine—Tension—Cyclosporine—systemic lupus erythematosus	0.000229	0.00415	CcSEcCtD
Pseudoephedrine—Bradycardia—Triamcinolone—systemic lupus erythematosus	0.000229	0.00414	CcSEcCtD
Pseudoephedrine—Bradycardia—Methylprednisolone—systemic lupus erythematosus	0.000228	0.00413	CcSEcCtD
Pseudoephedrine—Nervousness—Cyclosporine—systemic lupus erythematosus	0.000227	0.00411	CcSEcCtD
Pseudoephedrine—Muscle spasms—Cyclosporine—systemic lupus erythematosus	0.000225	0.00407	CcSEcCtD
Pseudoephedrine—Tension—Mycophenolate mofetil—systemic lupus erythematosus	0.000224	0.00405	CcSEcCtD
Pseudoephedrine—Insomnia—Leflunomide—systemic lupus erythematosus	0.000224	0.00405	CcSEcCtD
Pseudoephedrine—Hallucination—Methylprednisolone—systemic lupus erythematosus	0.000223	0.00404	CcSEcCtD
Pseudoephedrine—Nervousness—Mycophenolate mofetil—systemic lupus erythematosus	0.000222	0.00401	CcSEcCtD
Pseudoephedrine—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.00022	0.00399	CcSEcCtD
Pseudoephedrine—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.000219	0.00397	CcSEcCtD
Pseudoephedrine—Tremor—Cyclosporine—systemic lupus erythematosus	0.000219	0.00397	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisolone—systemic lupus erythematosus	0.000218	0.00395	CcSEcCtD
Pseudoephedrine—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000218	0.00394	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.000216	0.00391	CcSEcCtD
Pseudoephedrine—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000215	0.00389	CcSEcCtD
Pseudoephedrine—Agitation—Cyclosporine—systemic lupus erythematosus	0.000215	0.00389	CcSEcCtD
Pseudoephedrine—Tremor—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00387	CcSEcCtD
Pseudoephedrine—Arrhythmia—Hydrocortisone—systemic lupus erythematosus	0.000213	0.00386	CcSEcCtD
Pseudoephedrine—Pain—Leflunomide—systemic lupus erythematosus	0.000211	0.00383	CcSEcCtD
Pseudoephedrine—Vertigo—Cyclosporine—systemic lupus erythematosus	0.00021	0.0038	CcSEcCtD
Pseudoephedrine—Agitation—Mycophenolate mofetil—systemic lupus erythematosus	0.00021	0.0038	CcSEcCtD
Pseudoephedrine—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.000208	0.00376	CcSEcCtD
Pseudoephedrine—Bradycardia—Betamethasone—systemic lupus erythematosus	0.000208	0.00376	CcSEcCtD
Pseudoephedrine—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000207	0.00375	CcSEcCtD
Pseudoephedrine—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.000205	0.00371	CcSEcCtD
Pseudoephedrine—Irritability—Methotrexate—systemic lupus erythematosus	0.000205	0.00371	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000204	0.00369	CcSEcCtD
Pseudoephedrine—Hallucination—Dexamethasone—systemic lupus erythematosus	0.000203	0.00367	CcSEcCtD
Pseudoephedrine—Hallucination—Betamethasone—systemic lupus erythematosus	0.000203	0.00367	CcSEcCtD
Pseudoephedrine—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000202	0.00366	CcSEcCtD
Pseudoephedrine—Palpitations—Mycophenolate mofetil—systemic lupus erythematosus	0.000202	0.00365	CcSEcCtD
Pseudoephedrine—Arrhythmia—Triamcinolone—systemic lupus erythematosus	0.000201	0.00364	CcSEcCtD
Pseudoephedrine—Arrhythmia—Methylprednisolone—systemic lupus erythematosus	0.0002	0.00363	CcSEcCtD
Pseudoephedrine—Chest pain—Cyclosporine—systemic lupus erythematosus	0.000199	0.0036	CcSEcCtD
Pseudoephedrine—Anxiety—Cyclosporine—systemic lupus erythematosus	0.000198	0.00359	CcSEcCtD
Pseudoephedrine—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000197	0.00357	CcSEcCtD
Pseudoephedrine—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000195	0.00354	CcSEcCtD
Pseudoephedrine—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000194	0.00352	CcSEcCtD
Pseudoephedrine—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	0.000194	0.0035	CcSEcCtD
Pseudoephedrine—Confusional state—Cyclosporine—systemic lupus erythematosus	0.000192	0.00348	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisolone—systemic lupus erythematosus	0.000191	0.00346	CcSEcCtD
Pseudoephedrine—CYP2D6—nervous system—systemic lupus erythematosus	0.000189	0.00231	CbGeAlD
Pseudoephedrine—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.0034	CcSEcCtD
Pseudoephedrine—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000187	0.00338	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000184	0.00334	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisolone—systemic lupus erythematosus	0.000184	0.00333	CcSEcCtD
Pseudoephedrine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000182	0.00222	CbGeAlD
Pseudoephedrine—Arrhythmia—Betamethasone—systemic lupus erythematosus	0.000182	0.0033	CcSEcCtD
Pseudoephedrine—Arrhythmia—Dexamethasone—systemic lupus erythematosus	0.000182	0.0033	CcSEcCtD
Pseudoephedrine—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000182	0.00329	CcSEcCtD
Pseudoephedrine—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000182	0.00329	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisone—systemic lupus erythematosus	0.000181	0.00327	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.00018	0.00326	CcSEcCtD
Pseudoephedrine—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000179	0.00325	CcSEcCtD
Pseudoephedrine—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000177	0.00321	CcSEcCtD
Pseudoephedrine—Asthenia—Leflunomide—systemic lupus erythematosus	0.000177	0.00321	CcSEcCtD
Pseudoephedrine—Hallucination—Prednisone—systemic lupus erythematosus	0.000177	0.0032	CcSEcCtD
Pseudoephedrine—Anxiety—Hydrocortisone—systemic lupus erythematosus	0.000176	0.00319	CcSEcCtD
Pseudoephedrine—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000176	0.00318	CcSEcCtD
Pseudoephedrine—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000175	0.00318	CcSEcCtD
Pseudoephedrine—Dysuria—Methotrexate—systemic lupus erythematosus	0.000173	0.00314	CcSEcCtD
Pseudoephedrine—Dizziness—Azathioprine—systemic lupus erythematosus	0.000173	0.00314	CcSEcCtD
Pseudoephedrine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000173	0.00313	CcSEcCtD
Pseudoephedrine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.00017	0.00308	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000169	0.00307	CcSEcCtD
Pseudoephedrine—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000169	0.00306	CcSEcCtD
Pseudoephedrine—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000169	0.00305	CcSEcCtD
Pseudoephedrine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000168	0.00305	CcSEcCtD
Pseudoephedrine—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000168	0.00304	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000168	0.00304	CcSEcCtD
Pseudoephedrine—Vomiting—Azathioprine—systemic lupus erythematosus	0.000166	0.00301	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000166	0.00301	CcSEcCtD
Pseudoephedrine—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000166	0.003	CcSEcCtD
Pseudoephedrine—Anxiety—Methylprednisolone—systemic lupus erythematosus	0.000166	0.003	CcSEcCtD
Pseudoephedrine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000166	0.003	CcSEcCtD
Pseudoephedrine—Rash—Azathioprine—systemic lupus erythematosus	0.000165	0.00299	CcSEcCtD
Pseudoephedrine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000165	0.00299	CcSEcCtD
Pseudoephedrine—Headache—Azathioprine—systemic lupus erythematosus	0.000164	0.00297	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000164	0.00297	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000164	0.00297	CcSEcCtD
Pseudoephedrine—Dizziness—Leflunomide—systemic lupus erythematosus	0.000164	0.00296	CcSEcCtD
Pseudoephedrine—Pain—Cyclosporine—systemic lupus erythematosus	0.000163	0.00295	CcSEcCtD
Pseudoephedrine—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.00293	CcSEcCtD
Pseudoephedrine—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000162	0.00293	CcSEcCtD
Pseudoephedrine—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000161	0.00291	CcSEcCtD
Pseudoephedrine—Vertigo—Betamethasone—systemic lupus erythematosus	0.00016	0.00289	CcSEcCtD
Pseudoephedrine—Vertigo—Dexamethasone—systemic lupus erythematosus	0.00016	0.00289	CcSEcCtD
Pseudoephedrine—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000159	0.00288	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000159	0.00287	CcSEcCtD
Pseudoephedrine—Sweating—Methotrexate—systemic lupus erythematosus	0.000159	0.00287	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000157	0.00285	CcSEcCtD
Pseudoephedrine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000157	0.00285	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisolone—systemic lupus erythematosus	0.000157	0.00284	CcSEcCtD
Pseudoephedrine—Rash—Leflunomide—systemic lupus erythematosus	0.000156	0.00282	CcSEcCtD
Pseudoephedrine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000156	0.00282	CcSEcCtD
Pseudoephedrine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000156	0.00282	CcSEcCtD
Pseudoephedrine—Nausea—Azathioprine—systemic lupus erythematosus	0.000156	0.00282	CcSEcCtD
Pseudoephedrine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000156	0.00282	CcSEcCtD
Pseudoephedrine—Headache—Leflunomide—systemic lupus erythematosus	0.000155	0.0028	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000154	0.0028	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000154	0.00279	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000153	0.00278	CcSEcCtD
Pseudoephedrine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000153	0.00278	CcSEcCtD
Pseudoephedrine—Hypertension—Betamethasone—systemic lupus erythematosus	0.000153	0.00278	CcSEcCtD
Pseudoephedrine—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000153	0.00278	CcSEcCtD
Pseudoephedrine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000151	0.00273	CcSEcCtD
Pseudoephedrine—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000151	0.00273	CcSEcCtD
Pseudoephedrine—Anxiety—Betamethasone—systemic lupus erythematosus	0.000151	0.00273	CcSEcCtD
Pseudoephedrine—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000149	0.0027	CcSEcCtD
Pseudoephedrine—Pain—Prednisolone—systemic lupus erythematosus	0.000148	0.00269	CcSEcCtD
Pseudoephedrine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00267	CcSEcCtD
Pseudoephedrine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000147	0.00266	CcSEcCtD
Pseudoephedrine—Nausea—Leflunomide—systemic lupus erythematosus	0.000147	0.00266	CcSEcCtD
Pseudoephedrine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000145	0.00263	CcSEcCtD
Pseudoephedrine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000144	0.00262	CcSEcCtD
Pseudoephedrine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000144	0.00261	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000143	0.00259	CcSEcCtD
Pseudoephedrine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000142	0.00258	CcSEcCtD
Pseudoephedrine—Agitation—Prednisone—systemic lupus erythematosus	0.000142	0.00257	CcSEcCtD
Pseudoephedrine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000141	0.00256	CcSEcCtD
Pseudoephedrine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000141	0.00256	CcSEcCtD
Pseudoephedrine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000141	0.00255	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.00014	0.00254	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.00014	0.00254	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.00014	0.00254	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.00014	0.00253	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisone—systemic lupus erythematosus	0.000139	0.00252	CcSEcCtD
Pseudoephedrine—Anorexia—Betamethasone—systemic lupus erythematosus	0.000138	0.0025	CcSEcCtD
Pseudoephedrine—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000138	0.0025	CcSEcCtD
Pseudoephedrine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000137	0.00248	CcSEcCtD
Pseudoephedrine—Pain—Triamcinolone—systemic lupus erythematosus	0.000137	0.00247	CcSEcCtD
Pseudoephedrine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000134	0.00243	CcSEcCtD
Pseudoephedrine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00242	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisone—systemic lupus erythematosus	0.000133	0.00242	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000132	0.00238	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000131	0.00238	CcSEcCtD
Pseudoephedrine—Anxiety—Prednisone—systemic lupus erythematosus	0.000131	0.00238	CcSEcCtD
Pseudoephedrine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000131	0.00237	CcSEcCtD
Pseudoephedrine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000131	0.00237	CcSEcCtD
Pseudoephedrine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000128	0.00231	CcSEcCtD
Pseudoephedrine—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000128	0.00231	CcSEcCtD
Pseudoephedrine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000126	0.00229	CcSEcCtD
Pseudoephedrine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000126	0.00228	CcSEcCtD
Pseudoephedrine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000126	0.00228	CcSEcCtD
Pseudoephedrine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000126	0.00228	CcSEcCtD
Pseudoephedrine—Pain—Betamethasone—systemic lupus erythematosus	0.000124	0.00224	CcSEcCtD
Pseudoephedrine—Pain—Dexamethasone—systemic lupus erythematosus	0.000124	0.00224	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000123	0.00223	CcSEcCtD
Pseudoephedrine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.00223	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000122	0.00221	CcSEcCtD
Pseudoephedrine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000122	0.0022	CcSEcCtD
Pseudoephedrine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000121	0.0022	CcSEcCtD
Pseudoephedrine—Rash—Cyclosporine—systemic lupus erythematosus	0.00012	0.00218	CcSEcCtD
Pseudoephedrine—Anorexia—Prednisone—systemic lupus erythematosus	0.00012	0.00218	CcSEcCtD
Pseudoephedrine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.00012	0.00218	CcSEcCtD
Pseudoephedrine—Headache—Cyclosporine—systemic lupus erythematosus	0.00012	0.00216	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000119	0.00216	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000119	0.00216	CcSEcCtD
Pseudoephedrine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.00214	CcSEcCtD
Pseudoephedrine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.00213	CcSEcCtD
Pseudoephedrine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.00212	CcSEcCtD
Pseudoephedrine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000117	0.00211	CcSEcCtD
Pseudoephedrine—Vertigo—Methotrexate—systemic lupus erythematosus	0.000116	0.0021	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000115	0.00208	CcSEcCtD
Pseudoephedrine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000115	0.00207	CcSEcCtD
Pseudoephedrine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000115	0.00207	CcSEcCtD
Pseudoephedrine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000115	0.00207	CcSEcCtD
Pseudoephedrine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00207	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisone—systemic lupus erythematosus	0.000114	0.00207	CcSEcCtD
Pseudoephedrine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000113	0.00205	CcSEcCtD
Pseudoephedrine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000112	0.00203	CcSEcCtD
Pseudoephedrine—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000111	0.00201	CcSEcCtD
Pseudoephedrine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000111	0.002	CcSEcCtD
Pseudoephedrine—Chest pain—Methotrexate—systemic lupus erythematosus	0.00011	0.00199	CcSEcCtD
Pseudoephedrine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00011	0.00199	CcSEcCtD
Pseudoephedrine—Rash—Prednisolone—systemic lupus erythematosus	0.000109	0.00198	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000109	0.00198	CcSEcCtD
Pseudoephedrine—Headache—Prednisolone—systemic lupus erythematosus	0.000109	0.00197	CcSEcCtD
Pseudoephedrine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000108	0.00195	CcSEcCtD
Pseudoephedrine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00194	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00193	CcSEcCtD
Pseudoephedrine—Confusional state—Methotrexate—systemic lupus erythematosus	0.000106	0.00193	CcSEcCtD
Pseudoephedrine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000106	0.00192	CcSEcCtD
Pseudoephedrine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000106	0.00191	CcSEcCtD
Pseudoephedrine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00191	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000104	0.00188	CcSEcCtD
Pseudoephedrine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000104	0.00188	CcSEcCtD
Pseudoephedrine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000104	0.00188	CcSEcCtD
Pseudoephedrine—Nausea—Prednisolone—systemic lupus erythematosus	0.000103	0.00187	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000102	0.00185	CcSEcCtD
Pseudoephedrine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000102	0.00184	CcSEcCtD
Pseudoephedrine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00183	CcSEcCtD
Pseudoephedrine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000101	0.00182	CcSEcCtD
Pseudoephedrine—Rash—Triamcinolone—systemic lupus erythematosus	0.000101	0.00182	CcSEcCtD
Pseudoephedrine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000101	0.00182	CcSEcCtD
Pseudoephedrine—Anorexia—Methotrexate—systemic lupus erythematosus	0.000101	0.00182	CcSEcCtD
Pseudoephedrine—Rash—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00182	CcSEcCtD
Pseudoephedrine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00182	CcSEcCtD
Pseudoephedrine—Headache—Triamcinolone—systemic lupus erythematosus	0.0001	0.00181	CcSEcCtD
Pseudoephedrine—Headache—Methylprednisolone—systemic lupus erythematosus	9.98e-05	0.00181	CcSEcCtD
Pseudoephedrine—Body temperature increased—Prednisone—systemic lupus erythematosus	9.98e-05	0.00181	CcSEcCtD
Pseudoephedrine—Dizziness—Dexamethasone—systemic lupus erythematosus	9.58e-05	0.00173	CcSEcCtD
Pseudoephedrine—Dizziness—Betamethasone—systemic lupus erythematosus	9.58e-05	0.00173	CcSEcCtD
Pseudoephedrine—Insomnia—Methotrexate—systemic lupus erythematosus	9.54e-05	0.00173	CcSEcCtD
Pseudoephedrine—Nausea—Triamcinolone—systemic lupus erythematosus	9.49e-05	0.00172	CcSEcCtD
Pseudoephedrine—Nausea—Methylprednisolone—systemic lupus erythematosus	9.46e-05	0.00171	CcSEcCtD
Pseudoephedrine—Dyspnoea—Methotrexate—systemic lupus erythematosus	9.4e-05	0.0017	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.28e-05	0.00168	CcSEcCtD
Pseudoephedrine—Vomiting—Betamethasone—systemic lupus erythematosus	9.21e-05	0.00167	CcSEcCtD
Pseudoephedrine—Vomiting—Dexamethasone—systemic lupus erythematosus	9.21e-05	0.00167	CcSEcCtD
Pseudoephedrine—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.17e-05	0.00166	CcSEcCtD
Pseudoephedrine—Rash—Dexamethasone—systemic lupus erythematosus	9.14e-05	0.00165	CcSEcCtD
Pseudoephedrine—Rash—Betamethasone—systemic lupus erythematosus	9.14e-05	0.00165	CcSEcCtD
Pseudoephedrine—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.13e-05	0.00165	CcSEcCtD
Pseudoephedrine—Dermatitis—Betamethasone—systemic lupus erythematosus	9.13e-05	0.00165	CcSEcCtD
Pseudoephedrine—Headache—Dexamethasone—systemic lupus erythematosus	9.08e-05	0.00164	CcSEcCtD
Pseudoephedrine—Headache—Betamethasone—systemic lupus erythematosus	9.08e-05	0.00164	CcSEcCtD
Pseudoephedrine—Asthenia—Prednisone—systemic lupus erythematosus	9.05e-05	0.00164	CcSEcCtD
Pseudoephedrine—Pain—Methotrexate—systemic lupus erythematosus	9.02e-05	0.00163	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	8.69e-05	0.00157	CcSEcCtD
Pseudoephedrine—Nausea—Dexamethasone—systemic lupus erythematosus	8.61e-05	0.00156	CcSEcCtD
Pseudoephedrine—Nausea—Betamethasone—systemic lupus erythematosus	8.61e-05	0.00156	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisone—systemic lupus erythematosus	8.34e-05	0.00151	CcSEcCtD
Pseudoephedrine—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.34e-05	0.00151	CcSEcCtD
Pseudoephedrine—Vomiting—Prednisone—systemic lupus erythematosus	8.02e-05	0.00145	CcSEcCtD
Pseudoephedrine—Rash—Prednisone—systemic lupus erythematosus	7.96e-05	0.00144	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisone—systemic lupus erythematosus	7.95e-05	0.00144	CcSEcCtD
Pseudoephedrine—Headache—Prednisone—systemic lupus erythematosus	7.91e-05	0.00143	CcSEcCtD
Pseudoephedrine—Asthenia—Methotrexate—systemic lupus erythematosus	7.57e-05	0.00137	CcSEcCtD
Pseudoephedrine—Nausea—Prednisone—systemic lupus erythematosus	7.5e-05	0.00136	CcSEcCtD
Pseudoephedrine—Dizziness—Methotrexate—systemic lupus erythematosus	6.97e-05	0.00126	CcSEcCtD
Pseudoephedrine—Vomiting—Methotrexate—systemic lupus erythematosus	6.71e-05	0.00121	CcSEcCtD
Pseudoephedrine—Rash—Methotrexate—systemic lupus erythematosus	6.65e-05	0.0012	CcSEcCtD
Pseudoephedrine—Dermatitis—Methotrexate—systemic lupus erythematosus	6.64e-05	0.0012	CcSEcCtD
Pseudoephedrine—Headache—Methotrexate—systemic lupus erythematosus	6.61e-05	0.0012	CcSEcCtD
Pseudoephedrine—Nausea—Methotrexate—systemic lupus erythematosus	6.26e-05	0.00113	CcSEcCtD
Pseudoephedrine—IL2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.27e-05	7.35e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFB1—systemic lupus erythematosus	1.26e-05	7.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—C3—systemic lupus erythematosus	1.26e-05	7.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.26e-05	7.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—JAK1—systemic lupus erythematosus	1.22e-05	7.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.2e-05	6.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—F2—systemic lupus erythematosus	1.19e-05	6.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.17e-05	6.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TLR9—systemic lupus erythematosus	1.17e-05	6.76e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.16e-05	6.71e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.15e-05	6.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.15e-05	6.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TLR9—systemic lupus erythematosus	1.14e-05	6.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2RA—systemic lupus erythematosus	1.14e-05	6.6e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—systemic lupus erythematosus	1.14e-05	6.57e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.13e-05	6.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.13e-05	6.54e-05	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.12e-05	6.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—F2—systemic lupus erythematosus	1.11e-05	6.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.11e-05	6.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	1.1e-05	6.37e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.07e-05	6.22e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.07e-05	6.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.07e-05	6.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.07e-05	6.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.07e-05	6.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.06e-05	6.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NAT2—systemic lupus erythematosus	1.05e-05	6.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.04e-05	6.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.04e-05	6.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CSK—systemic lupus erythematosus	1.04e-05	6.02e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—systemic lupus erythematosus	1.03e-05	5.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.03e-05	5.94e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EP300—systemic lupus erythematosus	1.02e-05	5.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CSK—systemic lupus erythematosus	1.02e-05	5.89e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP9—systemic lupus erythematosus	1.02e-05	5.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	1.01e-05	5.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1e-05	5.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	9.94e-06	5.75e-05	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.92e-06	5.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—F2—systemic lupus erythematosus	9.92e-06	5.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	9.89e-06	5.72e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.81e-06	5.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.72e-06	5.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	9.72e-06	5.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	9.68e-06	5.6e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.65e-06	5.58e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EP300—systemic lupus erythematosus	9.64e-06	5.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.58e-06	5.54e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—systemic lupus erythematosus	9.55e-06	5.53e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—systemic lupus erythematosus	9.53e-06	5.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NCF2—systemic lupus erythematosus	9.52e-06	5.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	9.51e-06	5.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—C3—systemic lupus erythematosus	9.5e-06	5.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LYN—systemic lupus erythematosus	9.45e-06	5.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TLR9—systemic lupus erythematosus	9.45e-06	5.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.37e-06	5.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.31e-06	5.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NCF2—systemic lupus erythematosus	9.31e-06	5.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—C3—systemic lupus erythematosus	9.29e-06	5.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.27e-06	5.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LYN—systemic lupus erythematosus	9.25e-06	5.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—P2RY12—systemic lupus erythematosus	9.15e-06	5.29e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—systemic lupus erythematosus	9.13e-06	5.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.11e-06	5.27e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP9—systemic lupus erythematosus	9.09e-06	5.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.07e-06	5.25e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.05e-06	5.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	9.03e-06	5.23e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.85e-06	5.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.83e-06	5.11e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—RXRA—systemic lupus erythematosus	8.81e-06	5.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TLR9—systemic lupus erythematosus	8.78e-06	5.08e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—systemic lupus erythematosus	8.73e-06	5.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.7e-06	5.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	8.64e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.63e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—C3—systemic lupus erythematosus	8.63e-06	4.99e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EP300—systemic lupus erythematosus	8.62e-06	4.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.51e-06	4.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	8.5e-06	4.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—C3—systemic lupus erythematosus	8.44e-06	4.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CSK—systemic lupus erythematosus	8.42e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	8.38e-06	4.85e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—systemic lupus erythematosus	8.38e-06	4.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—F2—systemic lupus erythematosus	8.34e-06	4.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	8.3e-06	4.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ALB—systemic lupus erythematosus	8.24e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.16e-06	4.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—F2—systemic lupus erythematosus	8.16e-06	4.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	8.03e-06	4.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS3—systemic lupus erythematosus	7.88e-06	4.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	7.86e-06	4.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CSK—systemic lupus erythematosus	7.82e-06	4.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.75e-06	4.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	7.71e-06	4.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NCF2—systemic lupus erythematosus	7.7e-06	4.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—C3—systemic lupus erythematosus	7.69e-06	4.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LYN—systemic lupus erythematosus	7.65e-06	4.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.61e-06	4.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—F2—systemic lupus erythematosus	7.57e-06	4.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—JAK1—systemic lupus erythematosus	7.54e-06	4.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SH2B3—systemic lupus erythematosus	7.5e-06	4.34e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.49e-06	4.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JUNB—systemic lupus erythematosus	7.47e-06	4.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.44e-06	4.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—F2—systemic lupus erythematosus	7.41e-06	4.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	7.31e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JUNB—systemic lupus erythematosus	7.3e-06	4.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.2e-06	4.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	7.15e-06	4.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR5—systemic lupus erythematosus	7.14e-06	4.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	7.14e-06	4.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LYN—systemic lupus erythematosus	7.11e-06	4.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.1e-06	4.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	7.04e-06	4.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	7e-06	4.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—C3—systemic lupus erythematosus	6.98e-06	4.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.97e-06	4.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.94e-06	4.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRL—systemic lupus erythematosus	6.88e-06	3.98e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	6.84e-06	3.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.75e-06	3.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—F2—systemic lupus erythematosus	6.75e-06	3.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRL—systemic lupus erythematosus	6.73e-06	3.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—systemic lupus erythematosus	6.68e-06	3.87e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—systemic lupus erythematosus	6.67e-06	3.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.64e-06	3.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.6e-06	3.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.54e-06	3.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—C3—systemic lupus erythematosus	6.48e-06	3.75e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—systemic lupus erythematosus	6.31e-06	3.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	6.27e-06	3.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	6.16e-06	3.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.13e-06	3.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—F2—systemic lupus erythematosus	6.13e-06	3.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUNB—systemic lupus erythematosus	6.04e-06	3.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TYK2—systemic lupus erythematosus	6e-06	3.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—EP300—systemic lupus erythematosus	5.99e-06	3.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—RXRA—systemic lupus erythematosus	5.88e-06	3.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.74e-06	3.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.72e-06	3.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—F2—systemic lupus erythematosus	5.69e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—systemic lupus erythematosus	5.68e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—systemic lupus erythematosus	5.64e-06	3.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.62e-06	3.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	5.61e-06	3.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRL—systemic lupus erythematosus	5.57e-06	3.22e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARG—systemic lupus erythematosus	5.56e-06	3.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JAK1—systemic lupus erythematosus	5.5e-06	3.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.49e-06	3.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.46e-06	3.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JAK1—systemic lupus erythematosus	5.38e-06	3.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.33e-06	3.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR5—systemic lupus erythematosus	5.21e-06	3.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	5.21e-06	3.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	5.17e-06	2.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.14e-06	2.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR5—systemic lupus erythematosus	5.1e-06	2.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—systemic lupus erythematosus	5.1e-06	2.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—C3—systemic lupus erythematosus	5.1e-06	2.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	5.07e-06	2.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.03e-06	2.91e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—systemic lupus erythematosus	5e-06	2.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—systemic lupus erythematosus	4.99e-06	2.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—C3—systemic lupus erythematosus	4.98e-06	2.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.96e-06	2.87e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NOS3—systemic lupus erythematosus	4.78e-06	2.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.61e-06	2.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.54e-06	2.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—F2—systemic lupus erythematosus	4.47e-06	2.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.45e-06	2.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—F2—systemic lupus erythematosus	4.38e-06	2.53e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—systemic lupus erythematosus	4.37e-06	2.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CD80—systemic lupus erythematosus	4.29e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.22e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	4.22e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CD80—systemic lupus erythematosus	4.2e-06	2.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.16e-06	2.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	4.14e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	4.13e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	4.12e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—systemic lupus erythematosus	3.99e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	3.92e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—systemic lupus erythematosus	3.9e-06	2.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.86e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.83e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	3.83e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	3.83e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	3.71e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—EP300—systemic lupus erythematosus	3.64e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.62e-06	2.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	3.62e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.55e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TYK2—systemic lupus erythematosus	3.54e-06	2.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—systemic lupus erythematosus	3.48e-06	2.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	3.47e-06	2.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	3.36e-06	1.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	3.34e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	3.23e-06	1.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	3.22e-06	1.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	3.2e-06	1.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.08e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	3.01e-06	1.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.01e-06	1.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	3e-06	1.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	3e-06	1.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—systemic lupus erythematosus	2.95e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—systemic lupus erythematosus	2.93e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.93e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	2.92e-06	1.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.88e-06	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.85e-06	1.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.84e-06	1.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—systemic lupus erythematosus	2.79e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.78e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.72e-06	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	2.7e-06	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.67e-06	1.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EP300—systemic lupus erythematosus	2.64e-06	1.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.56e-06	1.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.5e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.49e-06	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	2.44e-06	1.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	2.43e-06	1.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.43e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	2.42e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.35e-06	1.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.31e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.31e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.3e-06	1.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.3e-06	1.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	2.26e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	2.25e-06	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	2.19e-06	1.27e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	2.18e-06	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	2.14e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.14e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	2.08e-06	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.07e-06	1.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	2.03e-06	1.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.92e-06	1.11e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.9e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.9e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	1.77e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.77e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—systemic lupus erythematosus	1.73e-06	1e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.58e-06	9.17e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	1.43e-06	8.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.33e-06	7.7e-06	CbGpPWpGaD
